Butterfly Network, Inc. (BFLY) Research
Butterfly Network, Inc. functions as a digital health enterprise, specializing in the invention, production, and global commercialization of cutting-edge ultrasound imaging technologies for both domestic and international markets. The company's innovative product portfolio includes the portable Butterfly iQ, a versatile single-probe system capable of whole-body ultrasound imaging, and the Butterfly iQ+, a point-of-care ultrasound device engineered to connect effortlessly with smartphones, tablets, and existing hospital computer networks. Additionally, Butterfly Blueprint is offered as a comprehensive, system-wide ultrasound platform that seamlessly integrates its proprietary Compass software into a healthcare provider's clinical and administrative infrastructure. These ultrasound systems, encompassing probes, related accessories, and software subscriptions, are supplied to healthcare systems, individual physicians, and other medical professionals through a multi-channel distribution strategy that includes a direct sales force, a network of distributors, and an e-commerce platform. Beyond its hardware, Butterfly Network provides a suite of cloud-based software solutions for healthcare organizations. These offerings feature teleguidance services, interactive in-app educational modules, and structured training programs delivered via its Butterfly Academy software, all complemented by dedicated clinical support and services. Established in 2011, Butterfly Network, Inc. has its corporate headquarters situated in Guilford, Connecticut.
Market snapshot
- Symbol
- BFLY
- Price
- $8.90
- Day change
- +55.87%
- Market cap
- $2.3B
- P/E ratio
- -30.13x
- 52-week range
- 1.32-8.94
- Sector
- Healthcare
- Industry
- Medical - Devices
- Next earnings
- in 1 month
- Analyst price target
- $5.42
Recent news
- Butterfly Network Climbs On Midjourney Hype Despite FDA, Reimbursement Questions
Butterfly Network Inc. (NYSE:BFLY) stock is trading higher on Thursday after it commented on Midjourney's announcement of Midjourney Medical and the Midjourney Scanner, a full-body tomographic imaging system.
- Butterfly Network gets FDA clearance for AI ultrasound pregnancy tool
Butterfly Network said on Monday it received U.S. regulatory clearance for an artificial intelligence-powered ultrasound tool that can estimate gestational age, a move the company said could expand access to maternal care in underserved areas.
Peer companies
Recent insider activity
- Cashman Steve — S-Sale (104781 shares) on 2026-06-05
- Cashman Steve — S-Sale (294680 shares) on 2026-06-08
- Caezza Nicholas — S-Sale (1733 shares) on 2026-06-02
- Neubauer Caroll H — A-Award (73170 shares) on 2026-05-19
- Neubauer Caroll H — trade (0 shares) on 2026-05-18
Open Butterfly Network, Inc. (BFLY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.